Literature DB >> 6237478

Unresponsiveness of the reproductive organs of the male mouse to treatment with a potent luteinizing hormone-releasing hormone agonist (ICI-118,630).

G J van Steenbrugge, J C Romijn, F H de Jong, F H Schröder.   

Abstract

The effects of administration of a luteinizing hormone-releasing hormone (LHRH) analogue (ICI-118,630) on plasma concentrations of hormones and weights of reproductive organs were studied in male mice. A single injection of the analogue (54 micrograms/kg body weight) caused a transient elevation of the concentration of LH in the plasma, up to 7 times the level in control mice. Daily administration of the analogue for a period of 3 weeks caused a small but significant decrease of the weight of the ventral prostate. The weight of the seminal vesicles in mice treated with the analogue, however, did not differ from that in control animals. The concentration of testosterone and LH in the plasma of these mice was not significantly different from those in control mice. It is demonstrated that the LHRH-analogue has no "castration-like" effect on the accessory sex organs of the male mouse, which is therefore not a suitable model in the study of these compounds.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6237478     DOI: 10.1007/bf00255918

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  16 in total

1.  Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.

Authors:  R Welschen; P Osman; J Dullaart; W J de Greef; J T Uilenbroek; F H de Jong
Journal:  J Endocrinol       Date:  1975-01       Impact factor: 4.286

2.  Evaluation of a radioimmunoassay for testosterone estimation.

Authors:  H L Verjans; B A Cooke; F H de Jong; C M de Jong; H J van der Molen
Journal:  J Steroid Biochem       Date:  1973-11       Impact factor: 4.292

3.  Pituitary and testicular functions in sexually mature rhesus monkeys under high-dose LRH-agonist treatment.

Authors:  F B Akhtar; E J Wickings; P Zaidi; E Nieschlag
Journal:  Acta Endocrinol (Copenh)       Date:  1982-09

4.  Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists.

Authors:  G Tolis; D Ackman; A Stellos; A Mehta; F Labrie; A T Fazekas; A M Comaru-Schally; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

5.  Human prostatic adenocarcinoma: some characteristics of a serially transplantable line in nude mice (PC 82).

Authors:  W Hoehn; F H Schroeder; J F Reimann; A C Joebsis; P Hermanek
Journal:  Prostate       Date:  1980       Impact factor: 4.104

6.  Synthesis and biological activity of highly active alpha-aza analogues of luliberin.

Authors:  A S Dutta; B J Furr; M B Giles; B Valcaccia
Journal:  J Med Chem       Date:  1978-10       Impact factor: 7.446

7.  Effect of chronic administration of a highly potent LHRH agonist on prostate size and secretory function in geriatric dogs.

Authors:  B H Vickery; G I McRae; H Bonasch
Journal:  Prostate       Date:  1982       Impact factor: 4.104

8.  Inhibition of serum androgen levels by chronic intranasal and subcutaneous administration of a potent luteinizing hormone-releasing hormone (LH-RH) agonist in adult men.

Authors:  N Faure; F Labrie; A Lemay; A Bélanger; Y Gourdeau; B Laroche; G Robert
Journal:  Fertil Steril       Date:  1982-03       Impact factor: 7.329

9.  Inhibition of prostate tumor growth in two rat models by chronic administration of D-Trp6 analogue of luteinizing hormone-releasing hormone.

Authors:  T W Redding; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

10.  Effects of high doses of a series of new luteinizing hormone-releasing hormone analogues in intact female rats.

Authors:  P V Maynard; R I Nicholson
Journal:  Br J Cancer       Date:  1979-03       Impact factor: 7.640

View more
  1 in total

1.  Does a gonadotropin-releasing hormone analogue prevent cisplatin-induced spermatogenic impairment? An experimental study in the mouse.

Authors:  M Nonomura; K Okada; S Hida; O Yoshida
Journal:  Urol Res       Date:  1991
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.